15
Participants
Start Date
November 30, 2003
Study Completion Date
January 31, 2008
Autologous peripheral blood CD34 positive cell therapy
Kobe City General Hospital, Kobe
Institute of Biomedical Research and Innovation, Kobe
Institute of Biomedical Research and Innovation, Kobe, Hyogo, Japan
OTHER
Kobe City General Hospital
OTHER
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
OTHER